Page last updated: 2024-08-24

atorvastatin and Glioblastoma

atorvastatin has been researched along with Glioblastoma in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's5 (50.00)24.3611
2020's4 (40.00)2.80

Authors

AuthorsStudies
Ai, J; Khanmohammadi, M; Malekshahi, ZV; Mokhberian, N; Mousavi, M; Nooshabadi, VT; Ranjbar, FE; Taghdiri-Nooshabadi, Z; Valipour, E1
Appelt-Menzel, A; Cubukova, A; Gohla, A; Haider, MS; Jeanclos, E; Kataoka, K; Kinoh, H; Krafft, M; Lübtow, MM; Luxenhofer, R; Meier, L; Oerter, S; Quader, S; Rist, M; Sampetrean, O; Schulte, C1
Aldanan, S; Alghareeb, WA; Alhussain, H; AlNajjar, FH; Alsaeed, E; Alsharm, AA; Altwairgi, AK; Balbaid, AAO; Orz, Y1
Ai, A; Ai, J; Ebrahimi-Barough, S; Farahani, MS; Goodarzi, A; Khanmohammadi, M; Khodayari, H; Khodayari, S; Mohandesnezhad, S1
Li, J; Long, C; Peng, P; Wei, W1
Ai, A; Ai, J; Bayat, N; Ebrahimi-Barough, S; Izadpanah, R; Mokhtari Ardakan, MM; Norouzi Javidan, A; Saberi, H1
Lei, C; Shuyun, H; Xiangrong, C; Yiquan, K; Yongjun, Y; Zhilin, Y1
Ai, A; Ai, J; Ardakan, MMM; Bayat, N; Ebrahimi-Barough, S; Norouzi-Javidan, A; Saberi, H; Shirian, S; Tajerian, R1
Ai, A; Ai, J; Ardakan, MMM; Bayat, N; Ebrahimi-Barough, S; Norouzi-Javidan, A; Saberi, H; Soleimannejad, M1
de Barros e Silva, MJ; de Paiva, TF; Fanelli, MF; Gimenes, DL; Rinck, JA1

Trials

1 trial(s) available for atorvastatin and Glioblastoma

ArticleYear
Atorvastatin in combination with radiotherapy and temozolomide for glioblastoma: a prospective phase II study.
    Investigational new drugs, 2021, Volume: 39, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Atorvastatin; Brain Neoplasms; Chemoradiotherapy; Female; Glioblastoma; Humans; Male; Middle Aged; Progression-Free Survival; Prospective Studies; Temozolomide; Young Adult

2021

Other Studies

9 other study(ies) available for atorvastatin and Glioblastoma

ArticleYear
The anti-angiogenic effect of atorvastatin loaded exosomes on glioblastoma tumor cells: An in vitro 3D culture model.
    Microvascular research, 2022, Volume: 143

    Topics: Angiogenesis Inhibitors; Atorvastatin; Cell Proliferation; Exosomes; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans

2022
    Molecular pharmaceutics, 2020, 06-01, Volume: 17, Issue:6

    Topics: Antineoplastic Agents; Atorvastatin; Blood-Brain Barrier; Cell Line, Tumor; Cell Movement; Cell Survival; Chromatography, High Pressure Liquid; Drug Compounding; Dynamic Light Scattering; Glioblastoma; Humans; Induced Pluripotent Stem Cells; Micelles; Nanomedicine; Neoplastic Stem Cells; Oxazoles

2020
Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model.
    Molecular biology reports, 2020, Volume: 47, Issue:10

    Topics: Animals; Atorvastatin; Cell Line, Tumor; Glioblastoma; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Neoplasms, Experimental; Rats; Rats, Wistar

2020
Atorvastatin augments temozolomide's efficacy in glioblastoma via prenylation-dependent inhibition of Ras signaling.
    Biochemical and biophysical research communications, 2017, 07-29, Volume: 489, Issue:3

    Topics: Animals; Atorvastatin; Brain Neoplasms; Cell Proliferation; Cell Survival; Dacarbazine; Disease Models, Animal; Glioblastoma; Humans; Mice; Neoplasms, Experimental; ras Proteins; Signal Transduction; Temozolomide; Tumor Cells, Cultured

2017
The Anti-Angiogenic Effect of Atorvastatin in Glioblastoma Spheroids Tumor Cultured in Fibrin Gel: in 3D in Vitro Model
    Asian Pacific journal of cancer prevention : APJCP, 2018, Sep-26, Volume: 19, Issue:9

    Topics: Angiogenesis Inhibitors; Anticholesteremic Agents; Atorvastatin; Cell Culture Techniques; Cell Movement; Cells, Cultured; Fibrin; Gels; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Neovascularization, Pathologic; Spheroids, Cellular

2018
Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression.
    Journal of neuroimmunology, 2013, Jul-15, Volume: 260, Issue:1-2

    Topics: Atorvastatin; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glioblastoma; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MAP Kinase Signaling System; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Microglia; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Pyrroles

2013
Apoptotic effect of atorvastatin in glioblastoma spheroids tumor cultured in fibrin gel.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 84

    Topics: Antineoplastic Agents; Apoptosis; Atorvastatin; Cell Movement; Dose-Response Relationship, Drug; Fibrin; Gels; Glioblastoma; Humans; Spheroids, Cellular; Tumor Cells, Cultured

2016
Anti-inflammatory Effects of Atorvastatin in Human Glioblastoma Spheroids Cultured in a Three-dimensional Model: Possible Relevance to Glioblastoma Treatment.
    Molecular neurobiology, 2018, Volume: 55, Issue:3

    Topics: Anti-Inflammatory Agents; Atorvastatin; Brain Neoplasms; Cell Culture Techniques; Cell Proliferation; Dose-Response Relationship, Drug; Glioblastoma; Humans; Inflammation Mediators; Spheroids, Cellular; Treatment Outcome

2018
Tuberculosis in a patient on temozolomide: a case report.
    Journal of neuro-oncology, 2009, Volume: 92, Issue:1

    Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antibiotics, Antitubercular; Anticholesteremic Agents; Anticonvulsants; Antineoplastic Agents, Alkylating; Atorvastatin; Brain Neoplasms; Combined Modality Therapy; Cyclosporine; Dacarbazine; Dexamethasone; Female; Fluoxetine; Glioblastoma; Heptanoic Acids; Humans; Immunosuppressive Agents; Isoniazid; Middle Aged; Omeprazole; Phenobarbital; Prednisone; Pyrazinamide; Pyrroles; Radiotherapy; Red-Cell Aplasia, Pure; Rifampin; Temozolomide; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary

2009